Table 2. Operative data and clinical outcomes.
| Median (range) | |
|---|---|
| ALPPS stage-1 | |
| Operative time (min) | 225 (130–390) |
| Blood loss (mL) | 150 (100–500) |
| RBC transfusion (U) | 0 |
| ALPPS stage-2 | |
| Operative time (min) | 175 (114–345) |
| Blood loss (mL) | 400 (200–1,500) |
| RBC transfusion (U) | 0 (0–4) |
| Total parenchymal transection (%) | 100.0 |
| R0 resection of tumor (%) | 100.0 (10/10) |
| Type of operation (three steps), n (%) | |
| Open ALPPS Stage-1; TAE; Open ALPPS Stage-2 | 8 (80.0) |
| Lapa ALPPS Stage-1; TAE; Lapa ALPPS Stage-2 | 1 (10.0) |
| Lapa ALPPS Stage-1; TAE; Open ALPPS Stage-2 | 1 (10.0) |
| Extent of resection | |
| Right hemihepatectomy, n (%) | 1 (10.0) |
| Extended right hemihepatectomy, n (%) | 9 (90.0) |
| Repeat laparotomy rate (%) | 0 |
| Postoperative hospital stay days | 14 (1–21) |
ALPPS, associating liver partition and portal vein ligation for staged hepatectomy; RBC, red blood cell; TAE, transcatheter arterial embolization; Lapa, laparoscopic.